Market revenue in 2024 | USD 7,073.8 million |
Market revenue in 2030 | USD 12,858.8 million |
Growth rate | 10.6% (CAGR from 2025 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Biologics, Drugs, Reproductive And Genetic, Nutrition |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal biotechnology market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 34.91% in 2024. Horizon Databook has segmented the U.S. animal biotechnology market based on diagnostics, biologics, drugs, reproductive and genetic, nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. animal biotechnology market, including forecasts for subscribers. This country databook contains high-level insights into U.S. animal biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account